Navigation path

HOME
Policy areas
Sectors
About competition policy
Cases & legislation
Current Issues
Contacts
What's new? | Manuals | Contact

 

Policy Area Case Number Member State Last Decision Date Title  
Merger M.1201 DUPONT / MERCK
Merger M.1397 SANOFI / SYNTHELABO
Merger M.1403 ASTRA / ZENECA
Merger M.1543 SANOFI / SYNTHELABO (Art.14 proc.) (see M.1397 and M.1542)
Merger M.3304 GE / AMERSHAM
Antitrust 37507 15.06.2005 Generics/Astra Zeneca
Cartel 37512 21.11.2001 Vitamins
Antitrust 39246 Boehringer
Antitrust 39612 09.07.2014 Perindopril (Servier)
Antitrust 39686 Cephalon
Antitrust 39812 22.07.2010 Pharma Sector Inquiry - Procedural Issue - Servier
Merger M.3990 BOOTS / ALLIANCE UNICHEM
Merger M.4007 RECKITT BENCKISER / BOOTS HEALTHCARE INTERNATIONAL
Merger M.5479 LONZA / TEVA / JV
Merger M.6091 GALENICA / FRESENIUS MEDICAL CARE / VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA JV
Merger M.6231 KKR / CAPSUGEL
Merger M.6258 TEVA / CEPHALON
Merger M.6280 PROCTER & GAMBLE / TEVA OTC BUSINESS
Merger M.6401 WATERLAND / ALYCHLO / OMEGA PHARMA
State Aid SA.33866 Italy 08.05.2012 Aiuto di Stato a favore di Ricerca, Sviluppo e Innovazione per il Progetto FAIV (Faster Access to Innovative Vaccines) di Novartis Vaccines S.r.l.
State Aid SA.39903 Romania Sprijin pentru consolidarea si modernizarea sectorului productiv prin investitii realizate de IMM si intreprinderi mari
State Aid X815/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (1)
State Aid X816/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (17)
State Aid X817/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (16)
State Aid X818/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (3)
State Aid X819/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (4)
State Aid X820/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (5)
State Aid X821/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (6)
State Aid X822/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (7)
State Aid X823/2009 Poland Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (8)




04-Mar-15